Virginia A. Schad, PharmD, RPh A real-world study found reslizumab reduces severe asthma exacerbations and oral corticosteroid (OCS) use in patients with severe eosinophilic asthma, both in biologic-naïve reslizumab initiators…
Beatrice Ragnoli*, Jaymin Morjaria*, Patrizia Pignatti, Paolo Montuschi, Mariangela Barbieri, Lucrezia Mondini, Luca Ruggero, Liliana Trotta, Mario Malerba Review Article. Ther Adv Chronic Dis. 2022 May 25;13:20406223221097327. https://doi.org/10.1177/20406223221097327 Abstract Bronchial asthma is a chronic inflammatory condition with increasing…
Virginia A. Schad, PharmD, RPh In children and adolescents, follow-up within 14 days of an asthma-related emergency department (ED) visit lowers the rate of subsequent asthma-related ED revisits in both…
Ron Goldberg Among adults with asthma, clear differences exist between comorbidities and disease characteristics based on the patient’s age of disease onset, with late-onset asthma more often being uncontrolled, according…
Review Open Access William J. Calhoun & Geoffrey L. Chupp Allergy, Asthma & Clinical Immunology volume 18, Article number: 42 (2022) Abstract Globally, a small proportion (5–12%) of asthma patients are estimated to have severe disease. However,…
Ron Goldberg Among patients with asthma, early and late allergic responses were reduced with omalizumab and tezepelumab, according to systematic review findings presented at the American Thoracic Society (ATS) International…
Virginia A. Schad, PharmD, RPh Omalizumab may decrease antitussive use in patients with allergic asthma, according to a study presented at the American Thoracic Society (ATS) International Conference 2022 held…
Ron Goldberg The use of correct inhaler technique is rarely checked, optimized, or reported among patients with asthma or COPD who take part in randomized controlled trials (RCTs) involving the…
Ron Goldberg Patients with severe asthma that had been poorly controlled with corticosteroids and beta-agonists experienced improved asthma control, fewer hospitalizations, fewer emergency department visits, and reduced corticosteroid use up…
Pam Brick A long-acting muscarinic antagonist (LAMA) significantly enhances lung function and lowers rescue medicine use in patients with overlapping asthma and chronic obstructive pulmonary disease (COPD), according to findings…